Sultan Abdulhamid Han Training and Research Hospital
Istanbul, 34668, Turkey (Türkiye)
Location contact
Hakan Emirkadı, MD
CONTACT
Hakan Emirkadı, MD
SUB_INVESTIGATOR
Tuna Ertürk, MD
CONTACT
Tuna Ertürk, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07705646
This randomized clinical trial will compare four ventilation strategies during retrograde intrarenal surgery performed under general anesthesia. The study aims to determine whether reducing respiratory-related kidney movement improves surgical success and decreases perioperative complications. Eighty adult patients will be randomly assigned to standard ventilation, hypoventilation, intermittent apnea ventilation, or one-lung ventilation. Surgical outcomes and perioperative complications will be compared between groups.
Trial opening soon.
Get Notified18 year–75 year
All sexes
Interventional
Not applicable
Istanbul, 34668, Turkey (Türkiye)
Hakan Emirkadı, MD
CONTACT
Hakan Emirkadı, MD
SUB_INVESTIGATOR
Tuna Ertürk, MD
CONTACT
Tuna Ertürk, MD
PRINCIPAL_INVESTIGATOR
Retrograde intrarenal surgery is commonly performed under general anesthesia, but respiratory movement may interfere with kidney stability during the procedure. This prospective, randomized, single-center trial will compare standard ventilation, hypoventilation, intermittent apnea ventilation, and one-lung ventilation in adult patients undergoing retrograde intrarenal surgery. The primary objective is to determine whether different ventilation strategies improve surgical success by reducing kidney movement. Secondary outcomes include operative time, stone access time, fluoroscopy time, laser use time, complications, length of hospital stay, and postoperative stone-free rate.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age 18-75 years. ASA physical status I-III. Scheduled for elective RIRS/RIRC under general anesthesia. No obstructive or restrictive pulmonary disease. No history of pneumothorax. No pulmonary mass or other significant respiratory disease. Normal coagulation parameters and not receiving antithrombotic therapy. No active urinary tract infection. Written informed consent.
Exclusion criteria
Age <18 or >75 years. ASA IV. Obstructive or restrictive pulmonary disease. History of pneumothorax. Pulmonary mass or significant respiratory disease. Receiving antithrombotic therapy or abnormal coagulation. Active urinary tract infection or urinary tract anatomical abnormality. Refusal or inability to provide informed consent.
Volume-controlled mechanical ventilation using standard ventilator settings during general anesthesia.
Volume-controlled mechanical ventilation using reduced tidal volume and respiratory rate during general anesthesia.
Intermittent apnea periods applied during selected stages of retrograde intrarenal surgery to reduce kidney motion.
One-lung ventilation applied during selected stages of retrograde intrarenal surgery to reduce kidney motion.
Time frame: During surgery
Kidney motion during surgery will be evaluated and compared among the four ventilation strategies.
Time frame: Postoperative Day 30
Percentage of patients who are stone-free after retrograde intrarenal surgery.
Time frame: During surgery
Total duration of surgery measured from the beginning to the end of the surgical procedure.
Time frame: During surgery
Total fluoroscopy exposure time recorded during the procedure.
Time frame: During surgery
Total duration of laser use during stone fragmentation.
Time frame: Periprocedural
Occurrence of intraoperative and postoperative complications.
Time frame: Periprocedural
Number of days of hospitalization.
Contact information is provided by the study sponsor or research team.
Hakan Emirkadı, MD
CONTACT
Tuna Ertürk, MD
CONTACT
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Other
Comparison of Different Ventilation Modes for Reducing Kidney Motion During Retrograde Intrarenal Surgery: A Prospective Randomized Controlled Trial
Acronym: RIRS-VENT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07712861
Calculi, Female Urogenital Diseases
Buenos Aires, Argentina
View Trial DetailsNCT07516535
Calculi, Female Urogenital Diseases
Cairo, Egypt
View Trial DetailsNCT07514351
Calculi, Female Urogenital Diseases
Columbus, Ohio, United States
View Trial DetailsNCT02214836
Calculi, Female Urogenital Diseases
Seattle, Washington, United States
View Trial Details